No evidence of mineralization abnormalities in iliac bone of premenopausal women with type 2 diabetes mellitus

J Musculoskelet Neuronal Interact. 2022 Sep 1;22(3):305-315.

Abstract

Objectives: Patients with type-2 diabetes mellitus (T2DM) have increased risk for bone fractures which points towards impaired bone quality.

Methods: We measured bone mineralization density distribution (BMDD) and osteocyte lacunae section (OLS) characteristics based on quantitative backscattered electron images of transiliac biopsy samples from n=26 premenopausal women with T2DM. Outcomes were compared to those from reference cohorts as well as between T2DM subgroups defined by clinical characteristics.

Results: Comparison to references did not reveal any differences in BMDD (all p>0.05) but a lowered OLS-density in cancellous bone in T2DM (-14.9%, p<0.001). Neither BMDD nor OLS-characteristics differed in T2DM subgroups defined by HbA1c (<7% versus >7%). The average degree of bone mineralization (CaMean) was higher (0.44 wt%Ca in T2DM, 0.30 wt%Ca in reference) and consistently the calcium concentration between the tetracycline double labels (CaYoung) was higher (0.76 wt%Ca, all p<0.001) in cancellous versus cortical bone.

Conclusions: Our findings suggest that bone matrix mineralization was neither affected by the presence nor by the glycemic control of T2DM in our study cohort. The intra-individual differences between cancellous and cortical bone mineralization gave evidence for differences in the time course of the early mineralization process in these compartments in general.

Keywords: Bone Matrix Mineralization; Mineralization Processes; Osteocyte Lacunae; Transiliac Bone Biopsy; Type-2 Diabetes Mellitus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Density
  • Bone and Bones
  • Calcification, Physiologic
  • Diabetes Mellitus, Type 2*
  • Female
  • Humans
  • Premenopause